These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 24523105)

  • 1. Enzyme kinetics in drug metabolism: fundamentals and applications.
    Nagar S; Argikar UA; Tweedie DJ
    Methods Mol Biol; 2014; 1113():1-6. PubMed ID: 24523105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case study 3. Application of basic enzyme kinetics to metabolism studies: real-life examples.
    Li Y; McCabe M; Podila L; Tracy TS; Tweedie DJ
    Methods Mol Biol; 2014; 1113():441-60. PubMed ID: 24523124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fundamentals of enzyme kinetics.
    Seibert E; Tracy TS
    Methods Mol Biol; 2014; 1113():9-22. PubMed ID: 24523106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consideration of the unbound drug concentration in enzyme kinetics.
    Waters NJ; Obach RS; Di L
    Methods Mol Biol; 2014; 1113():119-45. PubMed ID: 24523111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case study 1. Practical considerations with experimental design and interpretation.
    Barr JT; Flora DR; Iwuchukwu OF
    Methods Mol Biol; 2014; 1113():419-29. PubMed ID: 24523122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS; Maeng HJ; Fan J
    Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical steady-state enzyme kinetics.
    Lorsch JR
    Methods Enzymol; 2014; 536():3-15. PubMed ID: 24423262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different enzyme kinetic models.
    Seibert E; Tracy TS
    Methods Mol Biol; 2014; 1113():23-35. PubMed ID: 24523107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible mechanisms of enzyme inhibition and resulting clinical significance.
    Ring B; Wrighton SA; Mohutsky M
    Methods Mol Biol; 2014; 1113():37-56. PubMed ID: 24523108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions.
    Zhang L; Zhang Y; Huang SM
    Mol Pharm; 2009; 6(6):1766-74. PubMed ID: 19839641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology approaches to enzyme kinetics: analyzing network models of drug metabolism.
    Finn NA; Kemp ML
    Methods Mol Biol; 2014; 1113():317-34. PubMed ID: 24523119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pharmacokinetics and drug-drug interactions from in vitro metabolism data.
    Shou M
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):66-77. PubMed ID: 15679174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems.
    Baranczewski P; Edlund PO; Postlind H
    J Pharm Biomed Anal; 2006 Mar; 40(5):1121-30. PubMed ID: 16307862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of on-line systems using drug metabolizing enzymes integrated into capillary electrophoresis.
    Nowak P; Woźniakiewicz M; Kościelniak P
    Electrophoresis; 2013 Sep; 34(18):2604-14. PubMed ID: 23775897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of the allosteric kinetics of cytochrome P450s.
    Atkins WM
    Drug Discov Today; 2004 Jun; 9(11):478-84. PubMed ID: 15149623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of density functional theory in drug metabolism studies.
    Rydberg P; Jørgensen FS; Olsen L
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):215-27. PubMed ID: 24295134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of intersystem extrapolation factors in early reaction phenotyping and the quantitative extrapolation of human liver microsomal intrinsic clearance using recombinant cytochromes P450.
    Chen Y; Liu L; Nguyen K; Fretland AJ
    Drug Metab Dispos; 2011 Mar; 39(3):373-82. PubMed ID: 21148079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug metabolism and drug interactions: application and clinical value of in vitro models.
    Venkatakrishnan K; von Moltke LL; Obach RS; Greenblatt DJ
    Curr Drug Metab; 2003 Oct; 4(5):423-59. PubMed ID: 14529374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationalizing underprediction of drug clearance from enzyme and transporter kinetic data: from in vitro tools to mechanistic modeling.
    Galetin A
    Methods Mol Biol; 2014; 1113():255-88. PubMed ID: 24523117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Receptor-enzyme interactions. Kinetic characteristics].
    Varfolomeev SD
    Biokhimiia; 1988 Oct; 53(10):1677-83. PubMed ID: 2852966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.